--- title: "Decibel Cannabis Company Inc. has announced stock option grants effective Feb. 10, 2026. TSXV: DB, OTCQB: DBCCF." type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/275611234.md" description: "On February 11, 2026, Decibel Cannabis Company Inc. (Decibel), a prominent player in premium cannabis and extract products, revealed that it had approved a grant after the market closed on February 10, 2026. Decibel is listed on the TSXV as DB and OTCQB as DBCCF." datetime: "2026-02-11T13:03:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275611234.md) - [en](https://longbridge.com/en/news/275611234.md) - [zh-HK](https://longbridge.com/zh-HK/news/275611234.md) --- > 支持的语言: [English](https://longbridge.com/en/news/275611234.md) | [繁體中文](https://longbridge.com/zh-HK/news/275611234.md) # Decibel Cannabis Company Inc. has announced stock option grants effective Feb. 10, 2026. TSXV: DB, OTCQB: DBCCF. On February 11, 2026, Decibel Cannabis Company Inc. (Decibel), a prominent player in premium cannabis and extract products, revealed that it had approved a grant after the market closed on February 10, 2026. Decibel is listed on the TSXV as DB and OTCQB as DBCCF. ### 相关股票 - [Cannabis Bioscience International Holdings, Inc. (CBIH.US)](https://longbridge.com/zh-CN/quote/CBIH.US.md) - [Aurora Cannabis (ACB.US)](https://longbridge.com/zh-CN/quote/ACB.US.md) ## 相关资讯与研究 - [REGENXBIO To Report Duchenne Muscular Dystrophy Trial Results In Early Q2 2026](https://longbridge.com/zh-CN/news/278415162.md) - [Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium | IMUX Stock News](https://longbridge.com/zh-CN/news/278536359.md) - [](https://longbridge.com/zh-CN/news/278083953.md) - [Did ZoomInfo Technologies Inc. Insiders Breach their Fiduciary Duties to Shareholders? | GTM Stock News](https://longbridge.com/zh-CN/news/278929866.md) - [Key Cannabis Sector Investing Insights from the Latest Earnings Calls](https://longbridge.com/zh-CN/news/278990809.md)